Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By ...
DUBLIN--(BUSINESS WIRE)--The "Human Liver Model Market: Analysis by Product Type, Application, End-use, and Region - Size, Trends and Forecasts to 2030" report has been added to ResearchAndMarkets.com ...
News Medical on MSN
Cellarity's AI model predicts drug-induced liver injury
Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in ...
As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that ...
In a bid to gain further understanding of the etiology and pathogenesis of metabolic dysfunction–associated steatohepatitis (MASH), a team of researchers has created 3D bioprinted liver models. MASH, ...
A stained micrograph of 3D primary human liver cell tissue modeling MASH. Areas of fibrosis are indicated in blue. Image courtesy of Viscient Biosciences. Metabolic dysfunction- associated ...
A new method of 3D printing an anatomically accurate replica of the human liver is now helping to guide surgeons during tricky procedures. The 3D-printed replicas, which are made of transparent ...
Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and ...
Previous reports have also described the safety of resecting segments 7 and 8. However, they drew conclusions on smaller cohorts than our present study, and some included segments 1, 4a, 7, and 8, ...
Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and ...
Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback